{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:41:30Z","timestamp":1789144890053,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["e-tjo.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwan Journal of Ophthalmology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tjo.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T10:58:28Z","timestamp":1462013908000},"page":"119-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Challenges in the management of glaucoma in developing countries"],"prefix":"10.4103","volume":"6","author":[{"given":"Nadeem Hafeez","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hammad","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hassaan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.tjo.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib2","first-page":"774","article-title":"Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis","volume":"36","author":"Quigley","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.tjo.2016.01.004_bib3","first-page":"3216","article-title":"Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma","volume":"42","author":"Yucel","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.tjo.2016.01.004_bib4","first-page":"429","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"AGIS Investigators","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.tjo.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1167\/iovs.04-1529","article-title":"Prevalence of open-angle glaucoma in a rural south Indian population","volume":"46","author":"Vijaya","year":"2005","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"5","key":"10.1016\/j.tjo.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib9","first-page":"81","article-title":"Prevalence of primary glaucoma in an urban South Indian population","volume":"46","author":"Jacob","year":"1998","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bjo.2010.186924","article-title":"Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis","volume":"95","author":"Smg","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjo.2008.150698","article-title":"Agreement between spectral domain and time domain OCT for measuring RNFL thickness","volume":"93","author":"Vizzeri","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0079-6123(08)01130-8","article-title":"Assessment of neuroprotection in the retina with DARC","volume":"173","author":"Guo","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.tjo.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajo.2010.07.024","article-title":"Control of intraocular pressure and fluctuation with fixed combination brimonidine or timolol mono therapy","volume":"151","author":"Spaeth","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib14","series-title":"Primary Open-Angle Glaucoma. Preferred Practice Pattern","author":"American Academy of Ophthalmology","year":"2005"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.tjo.2016.01.004_bib15","first-page":"S7","article-title":"Evidence-based clinical practice guidelines for the management of glaucoma in the adult eye","volume":"44","author":"Canadian Ophthalmological Society","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib16","first-page":"w13545","article-title":"Continuous 24-hour intraocular pressure monitoring for glaucoma\u2014time for a paradigm change","volume":"142","author":"Mansouri","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.tjo.2016.01.004_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/02713683.2011.608240","article-title":"Continuous IOP fluctuation recording in normal tension glaucoma patients","volume":"36","author":"Pajic","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.tjo.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ceb.2008.01.002","article-title":"Applications for ROCK kinase inhibition","volume":"20","author":"Olson","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.tjo.2016.01.004_bib19","first-page":"474","article-title":"Vision and quality of life","volume":"92","author":"Brown","year":"1999","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.tjo.2016.01.004_bib20","first-page":"301","article-title":"Glaucoma patients' assessment of their visual function and quality of life","volume":"99","author":"Jampel","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.tjo.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factor for dry eye Syndrome","volume":"118","author":"Mors","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.tjo.2016.01.004_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Nocker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.tjo.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12325-008-0078-y","article-title":"Quantitative analysis of conjunctival goblet cells after chronic application of topical drops","volume":"25","author":"Kabook","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.tjo.2016.01.004_bib25","series-title":"Side effects of eye drops V compliance: patients' perspective. Program and abstracts of the World Glaucoma Congress 2009, July 8\u201311","author":"Al Naumi","year":"2009"},{"key":"10.1016\/j.tjo.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.icu.0000156139.05323.26","article-title":"Compliance and persistency in glaucoma follow up treatment","volume":"16","author":"Schwartz","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","article-title":"Doctor\u2013patient communication and health related beliefs: results from the Glaucoma Adherence and Persistency Study (GAPS)","volume":"115","author":"Friedman","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tjo.2016.01.004_bib28","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study\u00a0adherence to glaucoma medications: methodology of the Glaucoma Adherence and Persistency Study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.tjo.2016.01.004_bib29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2007.03.042","article-title":"Evaluation of practice pattern for the care of open angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study","volume":"114","author":"Quigley","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tjo.2016.01.004_bib30","first-page":"5262","article-title":"Rates of discontinuation and change of glaucoma therapy in a managed care setting","volume":"8","author":"Spooner","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.tjo.2016.01.004_bib31","first-page":"S 255","article-title":"Population based persistency rates for topical glaucoma medications measured with pharmacy claims data","volume":"8","author":"Dasgupta","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.tjo.2016.01.004_bib32","doi-asserted-by":"crossref","first-page":"S 13","DOI":"10.1016\/j.ajo.2003.10.034","article-title":"Persistency with Latanoprost or timolol in primary open angle glaucoma suspects","volume":"137","author":"Schwartz","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.tjo.2016.01.004_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/heart.88.2.203","article-title":"Effect of partial compliance on cardio vascular medication effectiveness","volume":"88","author":"Cravner","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.tjo.2016.01.004_bib34","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2005.02.030","article-title":"Glaucoma management among individuals enrolled in a single comprehensive insurance plan","volume":"112","author":"Friedman","year":"2005","journal-title":"Ophthalmology"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2211505616000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2211505616000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T08:19:01Z","timestamp":1498292341000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211505616000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2211505616000090"],"URL":"https:\/\/doi.org\/10.1016\/j.tjo.2016.01.004","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the management of glaucoma in developing countries","name":"articletitle","label":"Article Title"},{"value":"Taiwan Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.tjo.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}